Accoriding to" Boston Business Journal "Hypnion Inc. has nailed down $20 million in new venture funding thanks to favorable results
for its insomnia drug development program.
The Lexington, Mass,company said the latest round is an extension of a second round of financing.
Participating investors include MPM Capital
in Boston and San Francisco;Advanced Technology
Ventures in Waltham and Palo Alto, Calif.; Flagship Ventures in Cambridge; and Oxford Bioscience Partners in Boston.
To read more,visit http://www.bizjournals.com/industries/banking_financial_services/venture_capital/2005/12/19/boston_daily5.html</a>
